Description

5,9,10,14B-Tetrahydro-5-Methyl-2-(Trifluoromethyl)Isoquino[2,1-D][1,4]Benzodiazepin-6(7H)-One is a high-purity, complex heterocyclic compound featuring a fused isoquinoline and benzodiazepine core structure. This specialized chemical is valued for its unique molecular architecture, which makes it a critical advanced pharmaceutical intermediate in modern synthetic chemistry. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of novel active pharmaceutical ingredients (APIs) and other fine chemicals.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of complex drug candidates, particularly those targeting central nervous system (CNS) disorders.
• Medicinal Chemistry Research: Used as a scaffold or precursor in structure-activity relationship (SAR) studies and lead optimization programs.
• Organic Synthesis: Employed in advanced organic reactions to construct complex polycyclic frameworks for academic and industrial research.
• Reference Standard: Can be supplied as a high-purity analytical standard for method development and quality control in pharmaceutical analysis.
• Biochemical Research: Investigated for potential interactions with biological targets due to its benzodiazepine-like structure.

Basic Information

Product Name	5,9,10,14B-Tetrahydro-5-Methyl-2-(Trifluoromethyl)Isoquino[2,1-D][1,4]Benzodiazepin-6(7H)-One
CAS No.	10243-44-4
Molecular Formula	C20H16F3N3O
Molecular Weight	371.36 g/mol
Synonyms	5,9,10,14B-Tetrahydro-5-methyl-2-(trifluoromethyl)isoquino[2,1-d][1,4]benzodiazepin-6(7H)-one; 2-(Trifluoromethyl)-5,9,10,14b-tetrahydro-5-methylisoquino[2,1-d][1,4]benzodiazepin-6(7H)-one; Isoquino[2,1-d][1,4]benzodiazepin-6(7H)-one derivative; 10243-44-4; 5-Methyl-2-(trifluoromethyl)-5,9,10,14b-tetrahydroisoquino[2,1-d][1,4]benzodiazepin-6(7H)-one
EINECS	Contact for details

Quality Control

Our 5,9,10,14B-Tetrahydro-5-Methyl-2-(Trifluoromethyl)Isoquino[2,1-D][1,4]Benzodiazepin-6(7H)-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research and development. Certificates of Analysis (COA) detailing all test results are provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert gas purging to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.